Compound Detail
CHEMBL1201322
THONZONIUM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1201322 |
| Name | THONZONIUM |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | IOYZYMQFUSNATM-UHFFFAOYSA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
6
Publications
3
Known Names
Molecular Properties
511.8
MW (Da)
8.05
ALogP
4
HBA
0
HBD
38.2
PSA (Ų)
0.12
QED
2
Ro5 Violations
22
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Prescription |
| Chirality | Achiral |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| 36958266 | 10.1016/j.ejmech.2023.115290 | Unchecked | 1 |
| 36958266 | 10.1016/j.ejmech.2023.115290 | mRNA cap guanine-N7 methyltransferase | 1 |
| 38318365 | 10.1016/j.isci.2024.108907 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 1 |
Data from ChEMBL 36 via Core Engine